Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN115785181A reveals a green one-pot route for Mopiravir intermediates. Achieve high purity and yield with reduced costs for reliable pharmaceutical intermediates supply.
Novel catalytic method for Celecoxib intermediate offers high yield and mild conditions for reliable pharmaceutical supply chains.
Patent CN102643213B details a cyanide-free route for 3 5-dimethyl-4-bromomethylbenzonitrile ensuring safer manufacturing and supply chain stability for global pharmaceutical partners.
Novel one-step base-catalyzed synthesis reduces heavy metal use and simplifies purification for pharmaceutical intermediates supply chains globally.
Patent CN117304154A reveals a high-yield demethylation process for dimethylphrine analogs, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1910194A details a mercury-free spongosine synthesis route offering high purity and scalability for cost reduction in API manufacturing.
Advanced process for Imiquimod via novel iodo-intermediate and maleate purification. High-purity API intermediate manufacturing with optimized supply chain reliability.
Patent CN102070524A reveals a high-yield synthesis for quinoline derivatives, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN103965120A details novel quinazoline synthesis for EGFR inhibitors. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Efficient 3-step synthesis of 5α-reductase inhibitors via novel thioamide alkylation. Reduces complexity from legacy multi-step routes for API intermediates.
Novel purification method for Fidaxomicin using macroporous resins and polymer columns. Ensures >95% purity and scalable production for pharmaceutical partners.
Patent CN109912624B reveals a streamlined synthesis for Baloxavir key intermediates, offering significant cost reduction and improved supply chain reliability for pharmaceutical manufacturers.
Patent CN110981739B reveals a streamlined synthesis of Terbutaline Sulfate eliminating hydroxyl protection, offering cost reduction and enhanced supply chain reliability for pharmaceutical manufacturers.
Patent CN108147974A reveals low-temperature esterification for Carbidopa intermediate. Reduces energy, enables mother liquor recycling for cost efficiency and supply stability.
Advanced Grignard-based process for 3-bromo-4-trifluoromethylbenzaldehyde offers high yield and reduced waste for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN109180691B reveals an enzymatic route for C3-aromatic pyrroloindole alkaloids. This method offers high optical purity and scalable production for neuroprotective drug development.
Novel mild temperature route for Anastrozole production reduces impurities and eliminates column chromatography, ensuring cost-effective supply chain stability.
Patent CN120737012B reveals Amoc technology enabling high-purity polypeptide synthesis with reduced solvent waste and enhanced supply chain reliability for global buyers.
Novel Amoc technology enables low-concentration deprotection enhancing purity and reducing solvent waste for scalable polypeptide manufacturing.
Novel ruthenium-catalyzed route for high-purity carborane intermediates enabling cost-effective BNCT drug development and scalable supply chain solutions.